These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 3968640

  • 1. Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction.
    Loutzenhiser R, Epstein M, Horton C, Sonke P.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):382-7. PubMed ID: 3968640
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Renal microvascular actions of calcium antagonists.
    Loutzenhiser R, Epstein M.
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S3-12. PubMed ID: 16989072
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of the vasoconstrictor responses to potassium depolarization and norepinephrine and their antagonism by differing classes of vasodilators in the perfused rat hindquarters.
    Sybertz EJ, Vander Vliet G, Baum T.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):621-6. PubMed ID: 6317841
    [Abstract] [Full Text] [Related]

  • 8. Muzolimine modification of renal vasoconstriction.
    Steele TH, Challoner-Hue L.
    Z Kardiol; 1985 Dec; 74 Suppl 2():186-8. PubMed ID: 2408394
    [Abstract] [Full Text] [Related]

  • 9. The effects of sodium orthovanadate, noradrenaline and angiotensin II on isolated perfused rat kidney glomerular-tuft diameter.
    Corder CN, Pathak H, Kumar A, Wells A.
    Indian J Physiol Pharmacol; 1983 Dec; 27(3):193-9. PubMed ID: 6559748
    [Abstract] [Full Text] [Related]

  • 10. Contribution of Ca++ and calmodulin to the action of norepinephrine on renal prostaglandin synthesis and vascular tone.
    Cooper CL, Malik KU.
    J Pharmacol Exp Ther; 1986 Feb; 236(2):424-31. PubMed ID: 3080585
    [Abstract] [Full Text] [Related]

  • 11. Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused rat kidney.
    Loutzenhiser R, Epstein M, Horton C.
    Am J Cardiol; 1987 Jan 23; 59(2):72A-75A. PubMed ID: 3812264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal effects and vascular reactivity induced by Tityus serrulatus venom.
    de Sousa Alves R, do Nascimento NR, Barbosa PS, Kerntopf MR, Lessa LM, de Sousa CM, Martins RD, Sousa DF, de Queiroz MG, Toyama MH, Fonteles MC, Martins AM, Monteiro HS.
    Toxicon; 2005 Sep 01; 46(3):271-6. PubMed ID: 16011841
    [Abstract] [Full Text] [Related]

  • 14. Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists.
    Loutzenhiser R, Epstein M.
    Am J Nephrol; 1987 Sep 01; 7 Suppl 1():7-16. PubMed ID: 3442293
    [Abstract] [Full Text] [Related]

  • 15. Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
    el Din MM, Malik KU.
    J Pharmacol Exp Ther; 1988 Aug 01; 246(2):479-84. PubMed ID: 3404443
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of FK506-induced renal hypoperfusion and its reversion in rats.
    Chen JC, Ma P.
    Acta Pharmacol Sin; 2001 Nov 01; 22(11):1034-8. PubMed ID: 11749797
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.